¾È³çÇϼ¼¿ä À̹øÁÖ ¹ßÇ¥ÀÚ ´ÙÁ¤ÀÔ´Ï´Ù.
Á¦°¡ À̹ø¿¡ ¹ßÇ¥ÇÒ ³í¹®Àº 2020³â Cell reports¿¡ ÃâÆǵÈ
"The PD-1 pathway regulates development and function of memory CD8+ T cells following respiratory viral infection" ÀÔ´Ï´Ù.
À§ ³í¹®¿¡¼´Â completeÇÏ°Ô PD-1 signaling pathway¸¦ ¾ø¾ÝÀ» °æ¿ì Ãʹݿ¡´Â effector phase¿¡¼ ºü¸£°Ô virus clearance¸¦ ÀÌ·ê ¼ö ÀÖÁö¸¸ ÈÄ¿¡ memory formation¿¡ °áÇÔÀ» ¾ß±âÇÑ´Ù´Â °ÍÀ» È®ÀÎÇÏ¿´½À´Ï´Ù.
ÇÏÁö¸¸ PD-1À» blockadeÇÏ´Â timing°ú durationÀ» effector phase·Î Á¦ÇѽÃÅ°¸é ÃʹÝÀÇ T cell over-reactivationÀº ±×´ë·Î °¡Áö°í °¡¸é¼ memory formation¿¡´Â ¿µÇâÀ» ÁÖÁö ¾Ê´Â °ÍÀ» ¾Ë¾Æ³»¾ú½À´Ï´Ù.
µû¶ó¼ PD-1 pathway disruptionÀ» immune responseÁß ´Ù¸¥ stage¿¡ targetingÇÔÀ¸·Î½á CD8 T cellÀÇ differentiation°ú memory maintenance¿¡ Â÷À̸¦ ÁÙ ¼ö ÀÖÀ½À» º¸¿©ÁÖ¾î, PD-1À» ÀÌ¿ëÇÑ immunotherapyÀÇ »õ·Î¿î Àü·«À» ¹ß°ßÇس½ °Í¿¡ ÀÇÀÇ°¡ ÀÖ´Â ³í¹®ÀÔ´Ï´Ù.
¿½ÉÈ÷ ÁغñÇؼ Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
°¨»çÇÕ´Ï´Ù.
´ÙÁ¤¿Ã¸².
https://pubmed.ncbi.nlm.nih.gov/32610128/
- ´ÙÀ½±Û
- 5/22 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
- / °ü¸®ÀÚ
- ¾È³çÇϼ¼¿ä À̹øÁÖ ¹ßÇ¥ÀÚ Á¤Ã¶ÀÔ´Ï´Ù.
À̹øÁÖ Åä¿äÀÏ ¹ßÇ¥ÇÏ°Ô µÉ ³í¹®Àº 2021³â 2¿ù Nature medicine¿¡ ÃâÆÇµÈ Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial ÀÔ´Ï´Ù.
±âÁ¸ÀÇ ¾ÆÅäÇÇ Ä¡·á¹æ¹ýÀº skin inflammationÀ» Áõ..
- ÀÌÀü±Û
- 5¿ù 8ÀÏ Åä¿ä¼¼¹Ì³ª ¹ßÇ¥³í¹® ÀÔ´Ï´Ù.
- / °ü¸®ÀÚ
- ¾È³çÇϼ¼¿ä
À̹øÁÖ (5/8) Åä¿ä¼¼¹Ì³ª¿¡¼ Á¦°¡ ¹ßÇ¥ÇÒ ³í¹®Àº
Cell reports¿¡ 2019³â¿¡ ÃâÆǵÈ
'Maternal Antibodies Inhibit Neonatal and Infant Responses to Vaccination by Shaping the Early-Life B Cell Repertoire within Germinal Centers'ÀÔ´Ï´Ù.
Maternal antibody´Â ¸é¿ª ü°è°¡ ¿Ï..